ZA200107290B - Lactobacillus strains preventing diarrhoea pathogenic bacteria. - Google Patents

Lactobacillus strains preventing diarrhoea pathogenic bacteria.

Info

Publication number
ZA200107290B
ZA200107290B ZA200107290A ZA200107290A ZA200107290B ZA 200107290 B ZA200107290 B ZA 200107290B ZA 200107290 A ZA200107290 A ZA 200107290A ZA 200107290 A ZA200107290 A ZA 200107290A ZA 200107290 B ZA200107290 B ZA 200107290B
Authority
ZA
South Africa
Prior art keywords
pathogenic bacteria
lactobacillus strains
preventing diarrhoea
diarrhoea pathogenic
strains preventing
Prior art date
Application number
ZA200107290A
Other languages
English (en)
Inventor
Jean-Richard Neeser
Roberto Reniero
Alain Servin
Original Assignee
Nestle Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestle Sa filed Critical Nestle Sa
Publication of ZA200107290B publication Critical patent/ZA200107290B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
    • A23G9/00—Frozen sweets, e.g. ice confectionery, ice-cream; Mixtures therefor
    • A23G9/32—Frozen sweets, e.g. ice confectionery, ice-cream; Mixtures therefor characterised by the composition containing organic or inorganic compounds
    • A23G9/36—Frozen sweets, e.g. ice confectionery, ice-cream; Mixtures therefor characterised by the composition containing organic or inorganic compounds containing microorganisms or enzymes; containing paramedical or dietetical agents, e.g. vitamins
    • A23G9/363—Frozen sweets, e.g. ice confectionery, ice-cream; Mixtures therefor characterised by the composition containing organic or inorganic compounds containing microorganisms or enzymes; containing paramedical or dietetical agents, e.g. vitamins containing microorganisms, enzymes
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING OR TREATMENT THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/123—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
    • A23C9/1234—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt characterised by using a Lactobacillus sp. other than Lactobacillus Bulgaricus, including Bificlobacterium sp.
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/065—Microorganisms
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/11—Lactobacillus
    • A23V2400/175—Rhamnosus

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Dairy Products (AREA)
  • Confectionery (AREA)
  • Cereal-Derived Products (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
ZA200107290A 1999-03-11 2001-09-03 Lactobacillus strains preventing diarrhoea pathogenic bacteria. ZA200107290B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP99104922A EP1034787A1 (en) 1999-03-11 1999-03-11 Lactobacillus strains preventing diarrhea caused by pathogenic bacteria

Publications (1)

Publication Number Publication Date
ZA200107290B true ZA200107290B (en) 2003-02-26

Family

ID=8237746

Family Applications (2)

Application Number Title Priority Date Filing Date
ZA200107290A ZA200107290B (en) 1999-03-11 2001-09-03 Lactobacillus strains preventing diarrhoea pathogenic bacteria.
ZA200107293A ZA200107293B (en) 1999-03-11 2001-09-03 Lactobacillus strains capable of preventing diarhoea caused by pathogenic bacteria and rotaviruses.

Family Applications After (1)

Application Number Title Priority Date Filing Date
ZA200107293A ZA200107293B (en) 1999-03-11 2001-09-03 Lactobacillus strains capable of preventing diarhoea caused by pathogenic bacteria and rotaviruses.

Country Status (23)

Country Link
US (1) US6835376B1 (enExample)
EP (2) EP1034787A1 (enExample)
JP (1) JP2002537865A (enExample)
CN (1) CN1350461A (enExample)
AR (1) AR022912A1 (enExample)
AU (1) AU779414B2 (enExample)
BR (1) BR0008911A (enExample)
CA (1) CA2364435A1 (enExample)
CO (1) CO5241327A1 (enExample)
CZ (1) CZ20013264A3 (enExample)
HK (1) HK1042657A1 (enExample)
HU (1) HUP0200205A3 (enExample)
ID (1) ID30438A (enExample)
IL (2) IL145079A0 (enExample)
MY (1) MY125941A (enExample)
NO (1) NO20014299L (enExample)
NZ (1) NZ513806A (enExample)
PE (1) PE20001557A1 (enExample)
PL (1) PL355226A1 (enExample)
RO (1) RO121701B1 (enExample)
RU (2) RU2243779C2 (enExample)
WO (1) WO2000053200A1 (enExample)
ZA (2) ZA200107290B (enExample)

Families Citing this family (109)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7029702B2 (en) * 1998-07-07 2006-04-18 Ritter Natural Sciences Llc Method for increasing lactose tolerance in mammals exhibiting lactose intolerance
SE523771C2 (sv) * 1999-05-21 2004-05-18 Probi Ab Sportdryck innehållande mikronäringsämnen i kombination med levande laktobaciller
JP4343477B2 (ja) * 2000-05-25 2009-10-14 ソシエテ・デ・プロデュイ・ネスレ・エス・アー ペットフード用新規プロバイオチックス
SE0003100D0 (sv) 2000-09-01 2000-09-01 Probi Ab New strains
SE0003576D0 (sv) * 2000-10-04 2000-10-04 Probi Ab New strain
KR100419132B1 (ko) * 2000-12-29 2004-02-18 조성근 위·장 점막 부착성과 증식성, 내산성, 내담즙성 및헬리코박터 파일로리, 대장균 0157:ｈ7에 대한 항균성이우수한 락토바실러스 파라카제이 서브스패시즈 파라카제이ｃｓｋ 01
SE0103695D0 (sv) 2001-11-07 2001-11-07 Thomas Boren A novel non-antibiotic strategy against OGIP infections based on a cereal product
PT1485463E (pt) 2002-03-21 2008-12-30 Bifodan As Estirpes de lactobacillus
JP4308481B2 (ja) * 2002-06-18 2009-08-05 独立行政法人農業・食品産業技術総合研究機構 抗アレルギー剤
DK1565547T4 (da) 2002-06-28 2013-01-14 Biosearch S A Probiotiske stammer, en fremgangsmåde til selektion deraf, præparater deraf samt anvendelse deraf
EP1384483A1 (en) * 2002-07-23 2004-01-28 Nestec S.A. Probiotics for treatment of irritable bowel disease (IBS) through improvement of gut neuromuscular function
JP2004189672A (ja) * 2002-12-11 2004-07-08 Gen Corp:Kk 抗下痢症組成物
JPWO2004096246A1 (ja) * 2003-03-13 2006-07-13 麒麟麦酒株式会社 抗アレルギー用組成物
CA2526861A1 (en) * 2003-04-02 2004-10-14 Axcan Pharma S.A. Lactobacillus fermentum strain and uses thereof
US8877178B2 (en) 2003-12-19 2014-11-04 The Iams Company Methods of use of probiotic bifidobacteria for companion animals
US20050158294A1 (en) 2003-12-19 2005-07-21 The Procter & Gamble Company Canine probiotic Bifidobacteria pseudolongum
MY143693A (en) 2004-03-24 2011-06-30 Nestec Sa Shelf stable product wih living micro-organisms
ITRM20040166A1 (it) * 2004-03-31 2004-06-30 Alberto Cresci Ceppi batterici lab con proprieta' probiotiche e composizioni che contengono gli stessi.
US20080126195A1 (en) * 2004-07-22 2008-05-29 Ritter Andrew J Methods and Compositions for Treating Lactose Intolerance
TW200637908A (en) * 2005-01-04 2006-11-01 Calpis Co Ltd Method for preparation of lactic acid bacterium having anti-allergic activity
EP2108269A1 (en) 2005-04-13 2009-10-14 Nestec S.A. Infant formula with low dose probiotics and low dose proteins
US20060263311A1 (en) * 2005-05-19 2006-11-23 Scavone Timothy A Consumer noticeable improvement in wetness protection using solid antiperspirant compositions
BRPI0611492B1 (pt) 2005-05-31 2021-10-13 Mars, Incorporated Bifidobactéria probiótica felina
JP4938005B2 (ja) 2005-05-31 2012-05-23 ザ・アイムス・カンパニー ネコ科動物プロバイオティックであるラクトバシラス
EP1951273B1 (en) * 2005-10-06 2014-02-12 Probi Ab Use of lactobacillus for treatment of autoimmune diseases
ES2381211T3 (es) 2006-02-15 2012-05-24 Nestec S.A. Uso del Bifidobacterium longum para prevenir y tratar inflamaciones
ES2553636T3 (es) 2006-03-07 2015-12-10 Nestec S.A. Mezcla simbiótica
ATE478568T1 (de) * 2007-02-02 2010-09-15 May Amadeus Alexander Produkt mit lebenden probiotischen mikroorganismen
CN101273737B (zh) * 2007-03-28 2011-08-24 哈尔滨正方科技有限公司 一种在常温下保持高活菌数的发酵乳饮料的制备方法
EP1974735A1 (en) * 2007-03-28 2008-10-01 Nestec S.A. Reduction of risk of diarrhoea
EP1974743A1 (en) 2007-03-28 2008-10-01 Nestec S.A. Probiotics to Improve Gut Microbiota
DE602008005025D1 (de) * 2007-07-06 2011-03-31 Nutricia Nv Verwendung von probiotika und ballaststoffen bei diarrhö
US20090110663A1 (en) * 2007-10-24 2009-04-30 Halow George M Method for treatment of bowel disorders
EP2072052A1 (en) 2007-12-17 2009-06-24 Nestec S.A. Prevention of opportunistic infections in immune-compromised subjects
WO2009092628A1 (en) 2008-01-24 2009-07-30 Nestec S.A. Capsule containing nutritional ingredients and method of delivery of a nutritional liquid from the capsule
EP2265135B1 (en) 2008-03-14 2017-12-20 Nestec S.A. Synbiotic mixture
EP2127661A1 (en) 2008-05-27 2009-12-02 Nestec S.A. Probiotics to improve gut microbiotica
US9771199B2 (en) 2008-07-07 2017-09-26 Mars, Incorporated Probiotic supplement, process for making, and packaging
WO2010008491A2 (en) * 2008-06-25 2010-01-21 Ritter Natural Sciences, Llc Lactose compositions with decreased lactose content
EP2147678A1 (en) 2008-07-21 2010-01-27 Nestec S.A. Probiotics to increase IgA secretion in infants born by caesarean section
PL2166083T3 (pl) * 2008-12-31 2011-07-29 Syngen Biotech Co Ltd Nowy Lactobacillus paracasei SG96, zawierająca go kompozycja bakteriostatyczna oraz ich zastosowanie
US20100196341A1 (en) * 2009-02-05 2010-08-05 Syngen Biotech Co., Ltd. Novel Lactobacillus paracasei subsp. paracasei SG96, a Bacteriostatic Composition Containing the same and Use Thereof
WO2010098822A1 (en) 2009-02-24 2010-09-02 Ritter Pharmaceuticals, Inc. Prebiotic formulations and methods of use
CA2761573A1 (en) * 2009-05-11 2010-11-18 Nestec S.A. Bifidobacterium longum ncc2705 (cncm i-2618) and immune disorders
US10104903B2 (en) 2009-07-31 2018-10-23 Mars, Incorporated Animal food and its appearance
US9226521B2 (en) 2009-12-08 2016-01-05 Nestec S.A. Infant formula with probiotics and milk fat globule membrane components
EP3202406A1 (en) 2010-04-28 2017-08-09 Ritter Pharmaceuticals, Inc. Prebiotic formulations and methods of use
EP2510932A1 (en) * 2011-04-15 2012-10-17 Nestec S.A. Lactobacillus paracasei NCC2461 (ST11) for use by perinatal maternal administration in the reduction and prevention of allergies in progeny
WO2012177556A2 (en) 2011-06-20 2012-12-27 H.J. Heinz Company Probiotic compositions and methods
RU2654705C2 (ru) 2012-06-18 2018-05-22 Г.Дж. Хайнц Компани Брэндс ЛЛК Глютенозависимые расстройства
PT3470074T (pt) 2013-05-10 2020-11-30 Heinz Co Brands H J Llc Probióticos
US9688967B2 (en) 2014-12-05 2017-06-27 Synlogic, Inc. Bacteria engineered to treat diseases associated with hyperammonemia
US10610546B2 (en) 2015-05-13 2020-04-07 Synlogic Operating Company Inc. Bacteria engineered to reduce hyperphenylalaninemia
CN107208044B (zh) 2014-12-05 2021-08-13 同生运营公司 被工程化为治疗与高氨血症相关的疾病的细菌
BR112017011923A2 (pt) 2014-12-05 2018-02-27 Synlogic Inc bactéria modificada para tratar doenças associadas com hiperamonemia
US20160206666A1 (en) 2014-12-22 2016-07-21 Synlogic, Inc. Bacteria engineered to treat diseases that benefit from reduced gut inflammation and/or tighten gut mucosal barrier
JP7095993B2 (ja) 2015-03-02 2022-07-05 シンロジック オペレーティング カンパニー インコーポレイテッド 消化管炎症低下および／または消化管粘膜バリア強化の利益を享受する疾患処置のために操作された細菌
EP3294757B1 (en) 2015-05-13 2023-12-27 Synlogic Operating Company, Inc. Bacteria engineered to treat a disease or disorder
EP3307879A2 (en) 2015-06-10 2018-04-18 Synlogic, Inc. Bacteria engineered to treat diseases associated with hyperammonemia
WO2016210373A2 (en) 2015-06-24 2016-12-29 Synlogic, Inc. Recombinant bacteria engineered for biosafety, pharmaceutical compositions, and methods of use thereof
WO2016210384A2 (en) 2015-06-25 2016-12-29 Synlogic, Inc. Bacteria engineered to treat metabolic diseases
WO2016210378A2 (en) 2015-06-25 2016-12-29 Synlogic, Inc. Multi-layered control of gene expression in genetically engineered bacteria
WO2017023818A1 (en) 2015-07-31 2017-02-09 Synlogic, Inc. Bacteria engineered to treat disorders involving propionate catabolism
EP3344266A1 (en) 2015-08-31 2018-07-11 Synlogic, Inc. Bacteria engineered to treat disorders in which oxalate is detrimental
US11685925B2 (en) 2015-10-30 2023-06-27 Synlogic Operating Company, Inc. Bacteria engineered to treat diseases that benefit from reduced gut inflammation and/or tightened gut mucosal barrier
WO2017075485A1 (en) 2015-10-30 2017-05-04 Synlogic, Inc. Bacteria engineered to treat disorders in which trimethylamine (tma) is detrimental
WO2017074566A1 (en) 2015-10-30 2017-05-04 Dean Falb Bacteria engineered to treat diseases that benefit from reduced gut inflammation and/or tightened gut mucosal barrier
EP3377518B1 (en) 2015-11-16 2022-04-13 Synlogic Operating Company, Inc. Bacteria engineered to reduce hyperphenylalaninemia
WO2017123418A1 (en) 2016-01-11 2017-07-20 Synlogic, Inc. Bacteria engineered to treat metabolic diseases
US11723932B2 (en) 2016-01-11 2023-08-15 Synlogic Operating Company, Inc. Microorganisms programmed to produce immune modulators and anti-cancer therapeutics in tumor cells
WO2017123610A2 (en) 2016-01-11 2017-07-20 Synlogic, Inc. Bacteria engineered to detoxify deleterious molecules
WO2017123592A1 (en) 2016-01-11 2017-07-20 Synlogic, Inc. Bacteria engineered to treat disorders associated with bile salts
WO2017123676A1 (en) 2016-01-11 2017-07-20 Synlogic, Inc. Recombinant bacteria engineered to treat diseases and disorders associated with amino acid metabolism and methods of use thereof
WO2017136795A1 (en) 2016-02-04 2017-08-10 Synlogic, Inc. Bacteria engineered to treat diseases associated with tryptophan metabolism
AU2017213646A1 (en) 2016-02-04 2018-08-23 Synlogic Operating Company, Inc. Bacteria engineered to treat diseases that benefit from reduced gut inflammation and/or tightened gut mucosal barrier
WO2017139697A1 (en) 2016-02-10 2017-08-17 Synlogic, Inc. Bacteria engineered to treat diseases associated with hyperammonemia
WO2017139708A1 (en) 2016-02-10 2017-08-17 Synlogic, Inc. Bacteria engineered to treat nonalcoholic steatohepatitis (nash)
US11606965B2 (en) * 2016-05-11 2023-03-21 Chr. Hansen A/S Lactic acid bacteria for a heat-treated food product for storage at ambient temperature
AU2018205276A1 (en) 2017-01-06 2019-07-18 Synlogic Operating Company, Inc. Microorganisms programmed to produce immune modulators and anti-cancer therapeutics in tumor cells
US10941433B2 (en) 2017-06-15 2021-03-09 Iowa State University Research Foundation, Inc. Neurotransmitter transport in probiotics
AU2018290278B2 (en) 2017-06-21 2022-12-15 Synlogic Operating Company, Inc. Bacteria for the treatment of disorders
EP3651782A1 (en) 2017-07-12 2020-05-20 Synlogic Operating Company, Inc. Microorganisms programmed to produce immune modulators and anti-cancer therapeutics in tumor cells
US20210130806A1 (en) 2017-11-03 2021-05-06 Synlogic Operating Company, Inc. Engineered bacteria expressing racemase for treating diseases associated with hyperammonemia
CN110960559B (zh) * 2018-09-30 2021-02-26 内蒙古伊利实业集团股份有限公司 用于抑制口腔病原菌的乳酸菌菌株的食品、口腔清洁以及医药组合物
EP3822338A4 (en) 2018-09-30 2021-08-18 Inner Mongolia Yili Industrial Group Co., Ltd. LACTOBACILLUS PARACASEI ET-22 AND ITS USE
KR20220003030A (ko) 2019-04-29 2022-01-07 신로직 오퍼레이팅 컴퍼니, 인코포레이티드 살아 있는 세포 계수 기술에 의한 유전적으로 조작된 미생물의 계수
ES2983662T3 (es) 2019-07-23 2024-10-24 Frieslandcampina Nederland Bv Composición nutricional que comprende grasa láctea e inmunoglobulina
MX2022002949A (es) 2019-09-24 2022-04-06 Prolacta Bioscience Inc Composiciones y metodos para el tratamiento de enfermedades inflamatorias e inmunes.
EP4081229A1 (en) 2019-12-24 2022-11-02 Iowa State University Research Foundation, Inc. Control of histamine to promote health and control enterocolitis using probiotic compositions and/or histamine degrading enzymes
CN113355252A (zh) * 2020-03-06 2021-09-07 南京卫岗乳业有限公司 一种副干酪乳杆菌及其应用
BR112022018571A2 (pt) 2020-03-20 2022-11-01 Synlogic Operating Co Inc Microrganismos manipulados para reduzir a hiperfenilalaninemia
IL300573A (en) 2020-08-14 2023-04-01 Prolacta Bioscience Inc Breast milk oligosaccharide compositions for use with bacteriotherapy
AU2021393455A1 (en) 2020-12-02 2023-06-29 Synlogic Operating Company, Inc. Engineered microorganisms
CN116847860A (zh) 2020-12-31 2023-10-03 同生运营公司 经工程化以减轻高苯丙氨酸血症的微生物
JP2024502629A (ja) 2021-01-12 2024-01-22 プロラクタ バイオサイエンス，インコーポレイテッド シンバイオティック治療レジメン
CN112625983B (zh) * 2021-03-05 2021-05-28 山东中科嘉亿生物工程有限公司 一种对腹泻有治疗效果的干酪乳杆菌L.Casei21及其应用
CN112877260B (zh) * 2021-03-30 2022-08-09 江南大学 一株缓解泻剂结肠的副干酪乳杆菌及其应用
EP4323385A1 (en) 2021-04-13 2024-02-21 Synlogic Operating Company, Inc. Bacteria engineered to secrete active proteins
CN115671144A (zh) * 2021-07-26 2023-02-03 锦乔生物科技有限公司 使用乳酸菌菌株的培养物来抑制肠道病原菌生长和预防和/或治疗与肠道病原菌有关的疾病
WO2023044479A1 (en) 2021-09-17 2023-03-23 Synlogic Operating Company, Inc. Methods for reducing hyperphenylalaninemia
WO2023245171A1 (en) 2022-06-17 2023-12-21 Synlogic Operating Company, Inc. Bacteria engineered to treat diseases associated with bile acid metabolism and methods of use thereof
WO2023245168A1 (en) 2022-06-17 2023-12-21 Synlogic Operating Company, Inc. Bacteria engineered to treat diseases associated with bile acid metabolism and methods of use thereof
US20230414679A1 (en) 2022-06-22 2023-12-28 Iowa State University Research Foundation, Inc. Control of histamine to promote health and control enterocolitis using probiotic compositions
WO2023250478A1 (en) 2022-06-23 2023-12-28 Synlogic Operating Company, Inc. Recombinant bacteria engineered to treat diseases associated with methionine metabolism and methods of use thereof
WO2024081768A1 (en) 2022-10-12 2024-04-18 Synlogic Operating Company, Inc. Bacteria engineered to produce active epidermal growth factor (egf) and their medical uses
JP2025534764A (ja) 2022-10-17 2025-10-17 シンロジック オペレーティング カンパニー インコーポレイテッド 高フェニルアラニン血症を軽減するためのフェニルアラニンアンモニアリアーゼ、フェニルアラニントランスポーターおよびｌ－アミノ酸デアミナーゼを発現する組み換え細菌
WO2024129974A1 (en) 2022-12-14 2024-06-20 Synlogic Operating Company, Inc. Recombinant bacteria for use in the treatment of disorders in which oxalate is detrimental
WO2024130119A2 (en) 2022-12-16 2024-06-20 Prolacta Bioscience, Inc. Synbiotic compositions for short chain fatty acid production
EP4647439A1 (en) 2024-05-09 2025-11-12 Alma Mater Studiorum - Università di Bologna Non-pathogenic bacteria for delivery of ptd-fusion proteins

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0577903B1 (fr) * 1992-07-06 1997-12-17 Societe Des Produits Nestle S.A. Agent antigastrite
DK0768375T4 (da) * 1992-07-06 2002-09-16 Nestle Sa Mælkesyrebakterier
DE69501591T2 (de) * 1994-05-26 1998-06-10 Bracco Spa Lactobazillusstämme menschlichen ursprungs, ihre zusammensetzung und deren verwendung
JP3004890B2 (ja) * 1995-03-28 2000-01-31 雪印乳業株式会社 病原体感染防御剤
US5837238A (en) * 1996-06-05 1998-11-17 Biogaia Biologics Ab Treatment of diarrhea
IT1284877B1 (it) * 1996-08-09 1998-05-22 Dicofarm Spa Trattamento delle diarree acute del bambino e prevenzione della sensibilizzazione allergica verso alimenti introdotti nella fase
IT1289984B1 (it) * 1997-02-27 1998-10-19 Proge Farm Srl Ceppi di lattobacilli utili nel trattamento di disfunzioni del sistema gastrointestinale
SE511524C2 (sv) * 1997-06-02 1999-10-11 Essum Ab Lactobacillus casei rhamnosus-stam samt farmaceutisk beredning för bekämpning av patogena tarmbakterier
SE510813C2 (sv) * 1997-12-08 1999-06-28 Arla Ekonomisk Foerening Bakteriestam av arten Lactobacillus Paracasei subsp. paracasei, sammansättning därav för användning i livsmedel, samt produkt innehållande stammen
IL145080A0 (en) * 1999-03-11 2002-06-30 Nestle Sa Lactobacillus strains capable of preventing diarrhoea caused by pathogenic bacteria and rotaviruses

Also Published As

Publication number Publication date
CA2364435A1 (en) 2000-09-14
HUP0200205A2 (hu) 2002-05-29
US6835376B1 (en) 2004-12-28
IL145079A0 (en) 2002-06-30
IL145079A (en) 2006-08-01
PL355226A1 (en) 2004-04-05
PE20001557A1 (es) 2001-02-01
BR0008911A (pt) 2002-01-15
NO20014299D0 (no) 2001-09-04
HK1042657A1 (zh) 2002-08-23
EP1034787A1 (en) 2000-09-13
ZA200107293B (en) 2003-02-26
AR022912A1 (es) 2002-09-04
ID30438A (id) 2001-12-06
RO121701B1 (ro) 2008-02-28
WO2000053200A1 (en) 2000-09-14
EP1162986A1 (en) 2001-12-19
RU2247569C2 (ru) 2005-03-10
AU779414B2 (en) 2005-01-20
NZ513806A (en) 2003-08-29
CN1350461A (zh) 2002-05-22
HUP0200205A3 (en) 2002-06-28
AU3162700A (en) 2000-09-28
CO5241327A1 (es) 2003-01-31
RU2243779C2 (ru) 2005-01-10
CZ20013264A3 (cs) 2002-01-16
MY125941A (en) 2006-09-29
NO20014299L (no) 2001-11-05
JP2002537865A (ja) 2002-11-12

Similar Documents

Publication Publication Date Title
ZA200107290B (en) Lactobacillus strains preventing diarrhoea pathogenic bacteria.
ZA200107294B (en) Lactic acid bacteria strains capable of preventing diarrhoea.
HUP0303892A3 (en) Bacterial host strains
AU8685901A (en) High growth methanotrophic bacterial strain
EG24361A (en) 4-pyrimiding1-n-acy1.l.phenlalanines
ZA200201269B (en) Toothbrush.
IL160048A0 (en) Probiotic bifidobacterium strains
ZA200203768B (en) Toothbrush.
PL350776A1 (en) Lactobacillus strains capable of preventing diarrhoea caused by pathogenic bacteria and rotaviruses
IL132856A0 (en) Beverages containing live lactic bacteria
MXPA01009993A (es) Recipiente que tiene propiedades virucidales, bacteriales y/o germicidas.
MXPA02009342A (es) Uso de bacterias de acido lactico para el tratamiento de la peritonitis.
ZA200203170B (en) Mutant luciferase.
AU2001262250A1 (en) Probiotic lactic acid bacteria, unable to utilize lactose
AU7272900A (en) Phage resistant bacteria
ZA200407456B (en) Lactobacillus strains.
MXPA01011670A (es) Gen derivado de lawsonia y polipeptidos, peptidos y proteinas sodc relacionadso y sus usos.
MXPA01011570A (es) Gen derivado de lawsonia y polipeptidos, peptidos y proteinas relacionadas con peptido h de membrana externa.
MXPA01011669A (es) Gen derivado de lawsonia y polipeptidos, peptidos y proteinas relacionadas con fige y sus usos.
AU6427300A (en) Phage resistant lactic acid bacterial mutants
ZA200002320B (en) Coupling assemblies.
GB0000530D0 (en) Yoghurt drink
PL344936A1 (en) Flovoured yoghurt
AUPQ321099A0 (en) The always home service
ZA200001827B (en) Valve.